Insider trading
Officers, directors, and 10% owners buying and selling their own company's stock, from SEC Form 4 filings. Newest first.
Showing the last 10 days.Sign up free for 90 days
| Type | Symbol | Insider | Shares | Price | Value | Traded | Filed |
|---|---|---|---|---|---|---|---|
| Sell | HOOD | Bazzano Dara Chief Accounting Officer | 4,473 | $382K | Nov 2, 2026 | Nov 4, 2026 | |
| Other | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 13,979 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Other | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 19,544 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Grant | RES | Kolstad Gary A Director | 15,255 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Other | SUPN | Newhall Charles W Iii Director | 124,119 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | PENG | Clark Joseph Gates SVP and Pres, Optimized LED | 5,773 | $287K | Nov 2, 2026 | Nov 4, 2026 | |
| Other | SUPN | Hudson Frederick M. Director | 60,413 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Buy | UMBF | Peterman Tamara Director | 201 | $27K | Nov 2, 2026 | Nov 4, 2026 | |
| Other | STWD | Sternlicht Barry S CEO, Chairman of the Board, Director | 6,667 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | LGND | Reardon Andrew CLO & Secretary | 5,000 | $261K | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | LGND | Reardon Andrew CLO & Secretary | 5,000 | $1.6M | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | ALMS | Bradley Mark Christopher Chief Development Officer | 623 | $4K | Nov 2, 2026 | Nov 4, 2026 | |
| Grant | PGNY | Swartz Allison EVP, GC | 8,160 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | SHW | Garceau Mary L SVP - CLO and Secretary | 3,891 | $1.4M | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | OKLO | Bealmear Richard Craig Chief Financial Officer | 22,096 | $70K | Nov 3, 2026 | Nov 4, 2026 | |
| Sell | OKLO | Bealmear Richard Craig Chief Financial Officer | 16,727 | $427K | Nov 2, 2026 | Nov 4, 2026 | |
| Buy | TBBK | Tryniski Mark E Director | 5,000 | — | Nov 3, 2026 | Nov 4, 2026 | |
| Sell | OKLO | Cochran Caroline Co-Founder, COO, Director, 10% owner | 80,000 | $2.0M | Nov 2, 2026 | Nov 4, 2026 | |
| Buy | KNOP | Seglem Trygve Director | 2,083,333 | $43.5M | Nov 3, 2026 | Nov 4, 2026 | |
| Sell | BLND | Ghamsari Nima HEAD OF BLEND, Director | 22,322 | $26K | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | YELP | Amara Carmen Chief People Officer | 500 | $10K | Nov 2, 2026 | Nov 4, 2026 | |
| Grant | SEER | Endweiss Charles VP Financial Planning Analysis | 35,000 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | VSAT | Palmer Benjamin Edward SVP, Pres Commercial | 2,000 | $154K | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | AIP | Bayview Legacy, LLC 10% owner | 100,000 | $1.8M | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | AIP | Janac K Charles President and CEO, Director, 10% owner | 100,000 | $1.8M | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | REGN | Sing George L Director | 15,269 | $5.8M | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | REGN | Sing George L Director | 21,129 | $20.4M | Nov 2, 2026 | Nov 4, 2026 | |
| Buy | AN | Manley Michael Mark CEO and Director, Director | 5,600 | $1.0M | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | NEOG | Yarwood Jeremy Chief Scientific Officer | 16,207 | $192K | Nov 3, 2026 | Nov 4, 2026 | |
| Tax | NEOG | Yarwood Jeremy Chief Scientific Officer | 7,156 | $85K | Nov 3, 2026 | Nov 4, 2026 | |
| Sell | NEOG | Yarwood Jeremy Chief Scientific Officer | 9,051 | $115K | Nov 4, 2026 | Nov 4, 2026 | |
| Sell | META | Andreessen Marc L Director | 20,951 | $12.8M | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | REGN | Poon Christine A Director | 7,830 | $2.9M | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | REGN | Poon Christine A Director | 7,830 | $7.6M | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | PBF | Davis Karen Berriman Director | 12,117 | $938K | Nov 3, 2026 | Nov 4, 2026 | |
| Sell | BBNX | Hopman Mark Chief Commercial Officer | 370 | $6K | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | REGN | Fenimore Christopher R. EVP Finance CFO | 6,000 | $2.3M | Nov 2, 2026 | Nov 4, 2026 | |
| Tax | REGN | Fenimore Christopher R. EVP Finance CFO | 4,243 | $4.0M | Nov 2, 2026 | Nov 4, 2026 | |
| Gift | REGN | Fenimore Christopher R. EVP Finance CFO | 15 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | HIG | Costello Beth Ann EVP and CFO | 31,597 | $1.7M | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | HIG | Costello Beth Ann EVP and CFO | 31,597 | $4.3M | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | MRSH | Tomlinson Patrick Pres/CEO, Marsh People & Inv | 2,500 | $208K | Nov 2, 2026 | Nov 4, 2026 | |
| Tax | MRSH | Tomlinson Patrick Pres/CEO, Marsh People & Inv | 1,775 | $361K | Nov 2, 2026 | Nov 4, 2026 | |
| Grant | DXLG | Bauza Carmen Director | 40,099 | $18K | Nov 2, 2026 | Nov 4, 2026 | |
| Gift | CDNA | Cohen Fred E Director | 25,000 | — | Nov 3, 2026 | Nov 4, 2026 | |
| Sell | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 7,195 | $190K | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | GENB | Arnold Frances Director | 11,409 | $185K | Oct 29, 2026 | Nov 4, 2026 | |
| Exercise | REGN | Larosa Joseph J EVP General Counsel and Secret | 12,283 | $4.7M | Nov 2, 2026 | Nov 4, 2026 | |
| Tax | REGN | Larosa Joseph J EVP General Counsel and Secret | 8,686 | $8.3M | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | REGN | Larosa Joseph J EVP General Counsel and Secret | 4,466 | $4.3M | Nov 2, 2026 | Nov 4, 2026 |